Vivus, Why the Slide? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vivus, Why the Slide?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DDS-OMS who wrote (3067)	8/19/1997 8:14:00 AM
From: Richard Singer	of 3991

Gary- Generally speaking, you are certainly correct, but I have to respectfully disagree on this occasion, considering THIS market. We have all seen recent market reaction to earnings releases which exceed, or fail to meet analyst projections. The most recent example for me was PTEK, which met analyst projections, but reported a well-publicized, one-time charge against the quarter for merger consolidation. The stock promptly dropped 15% - This kind of action appears to be the current norm, and any dollars that Vivus reports above the expected ones should attract buyers, uninformed or otherwise.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next